Allison Betof Warner

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Allison Betof Warner
Mar 31, 2025, 15:45 | Blog
Allison Betof Warner: Last Call for Abstracts to the 2025 SNO/ASCO CNS Metastasis Conference
Allison Betof Warner, Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford…
Jan 14, 2025, 13:28 | Blog
Allison Betof Warner: Another landmark day for solid tumor cell therapy at Stanford Cancer Institute
Allison Betof Warner, Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford…
Nov 26, 2024, 11:37 | Blog
Allison Betof Warner: Grateful for the invitation to co-Chair the IO Session at the AACR-KCA Precision Medicine conference
Allison Betof Warner, Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford…
Nov 11, 2024, 11:50 | Societies
Highlights from the 39th Society for Immunotherapy of Cancer Annual Meeting
The 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting was held from November 6–10, 2024,…
Sep 19, 2024, 04:32 | Societies
Best of ESMO24
The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at…
Sep 9, 2024, 07:34 | Blog
Allison Betof Warner: Looking forward to ESMO24!
Allison Betof Warner, Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford…
Aug 11, 2024, 12:43 | Blog
Oncology Brothers: Melanoma Treatment Algorithm with Allison Betof Warner
Rahul Gosain posted on LinkedIn: "Melanoma: with Allison Betof Warner we the SoC for early, locally…
Jul 1, 2024, 02:27 | Blog
Krishna Komanduri: Big deal and a win for immunotherapy patients
Krishna Komanduri, Physician in Chief at UCSF Helen Diller Family Comprehensive Cancer Center, made the following post…
Jun 5, 2024, 13:41 | Societies
Allison Betof Warner: Headed home from a hugely successful ASCO24
Allison Betof Warner,Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford Cancer…
Jun 2, 2024, 09:37 | Insight
Allison Betof Warner: Relativity-048 presented by Paolo A. Ascierto at ASCO24
Allison Betof Warner, Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford…
Apr 14, 2024, 07:51 | Insight
New Paper Alert! Defining Dermatologic Immune-Related Adverse Events: A Consensus-Driven Approach
Defining Dermatologic Immune-Related Adverse Events: A Consensus-Driven Approach  Published in Journal for ImmunoTherapy of Cancer,…
Apr 8, 2024, 20:03 | Drugs
Allison Betof Warner: Our Melanoma and Cell Therapy teams at Stanford Cancer Institute performed the first commercial lifileucel infusion
Allison Betof Warner, Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford…
Feb 23, 2024, 17:44 | Drugs
Allison Betof Warner: The TIL team at Stanford Cancer Institute did our first surgical tumor harvest for AMTAGVI (lifileucel) this morning!
Allison Betof  Warner, Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford…
All: 13 Posts: 1 - 100
Special Coverage